NEW YORK, Feb. 14 (GenomeWeb News) - Agilent Technologies' Life Science and Chemical Analysis business unit today reported a 16-percent increase in orders for the quarter ended Jan. 31, 2005, accompanied by a 13-percent rise in revenues and a 9-percent increase in profits.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: flu susceptibility and Y chromosome variation in mice, deletion tied to epilepsy in dog breed, and more.
Sequencing is enabling the roots of some rare diseases to be determined, the Financial Times reports.
Proove Biosciences had allegedly been paying doctors to perform its opioid risk and other genetic tests, Stat News reports.
A floated budget plan could see non-military discretionary spending in the US — which includes science agency funding — fall, the New York Times reports.